Covid-19
Evidence-based explanations of the Covid-19 pandemic, including how it started, how it might end, and how to protect yourself and others.
The CDC is encouraging Covid-19 booster shots now while we wait on more omicron variant data. Here’s why.
It couldn’t delay omicron’s arrival, and may do little to delay the variant’s spread.
Omicron is the latest product of a global Covid-19 response that isn’t good enough.
How will we know if the omicron variant is actually a big deal?
Omicron is the newest Covid-19 “variant of concern,” according to the World Health Organization.
Health insurance premiums could spike in 2022, experts warn.
Politics — or the lack thereof — was a key factor.
Supply chains are screwing with prices for a lot of the world.
The number of American kids whose caregivers have died in the pandemic has surpassed 140,000.
Yes, we’re still in a pandemic — but there are some things to be grateful for amid a difficult stretch for humanity.
New tests promise lab-quality results in under an hour — all without having to get up off your couch.
Should I get it? And, if I do, am I taking a dose from someone who needs it more?
America’s public servants face a wave of threats that reveal a democracy rotting from within.
BioNTech’s Özlem Türeci talks about the scientific process, the state of the pandemic, and the global vaccine gap.
From the why to the who, we still need a lot of answers about booster shots.
Covid-19 treatments are key to living with the virus. Here’s where we’re at.
The Biden administration wants to protect millions from Covid-19, but it faces an uphill fight in a GOP-dominated judiciary.
Half the world has gotten a Covid-19 shot. Yet the vaccination rate in some countries is less than 10 percent.
Burnout, vaccine hesitancy, and plum traveling gigs are making it harder for hospitals to hire the nurses they need.
Schools and other officials can try persuasion first, but — eventually — they should be ready to do more.
All of Vox’s coverage on the complicated reopening of schools during the Covid-19 pandemic.
5- to 11-year-olds are now eligible for the Pfizer/BioNTech vaccine. That could be a game changer for families and schools.
Why hospitality employees won’t go back to work.
Democrats’ plans for public health funding fall far short of what experts say is necessary.
It’s time to rethink how American children play.
Brazilian lawmakers may try to make the case, though experts are skeptical of how far it could go.
Experts agree that high prices and low supplies aren’t going away just yet.
A Covid-19 vaccine for children ages 5 to 11 could be authorized by early November.
Three big questions about booster shots, answered.
It’s more subjective than you might think.
Thus far, the justices have not given much comfort to anti-vaxxers. That could change soon.
A key feature of the Excelsior Pass app is rarely used.
Scientists don’t want you to be going out right now. But if you must …
The pharma giant said its new antiviral drug cut hospitalizations in half for at-risk Covid-19 patients.
Why this winter should be better than the last one.
The most popular holiday gifts might not arrive in time for the holidays, even if you order now.
Children are at much lower risk of Covid-19 than adults. But what does that actually mean?
Inside the upside-down world where Covid-19 vaccines are dangerous and ivermectin is saving lives.
Why some people might need a booster shot right now — and some might not.
Why some people might need Covid-19 booster shots — and some might not.